5-Boc-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine, 97.0%, 250mg

TETRAKIS(4-FORMYLPHENYL)METHANE, 95%, 250mg

(1R,2R)-2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 1g

(4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride, 98.0%, 5g

Lámina de platino 99,9% 0,1 x 50 x 50 mm 1 ud.

4-Acetylthiophene-2-carboxylic acid, 98%, 250mg

4-((4-Chlorophenyl)thio)aniline, 97%, 5g

[(6-Nitro-1,3-benzothiazol-2-yl)thio]acetic acid, 95.0%, 500mg

4-(Methylsulfanyl)pyridine, 95%, 100mg

Psoralidin>98.0%(HPLC)100mg

8-Bromo-6-chloroimidazo[1,2-a]pyridine-3-carbaldehyde, 95.0%, 250mg

1-BROMO-7-FLUOROISOQUINOLINE, 95.0%, 5g

1,4-Dioxano, 5 l, aluminio